Skip to content
★ Sign in to follow
JF

John F. Finn

Board Director
Director
Total declarations
51
Companies
2
▲ Purchases (2 ops.)
€72k
▼ Sales (5 ops.)
€1.1M

Latest filing published 03 Mar 2022 for GREIF, INC.

Insider track record

Disclosed buys
2
Disclosed sells
5
Signal history

No signal scores available.

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-0.9%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 08 Sept 2011 · 5540 days ago · €29k
    -0.3%
    Entry US$46.36 · Close at T+365 US$46.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

John F. Finn: trading record in brief

John F. Finn is a declared insider at 2 companies (board member); the most frequent names are Cardinal Health Inc and Greif, Inc. Over a trading history stretching from 30 August 2006 to 1 March 2022, the count stands at 51 filings.

On the open market, the record shows 2 purchases worth €72k and 5 sales worth €1.1M. On balance, insiders were net sellers of €1.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 26 share grants and 9 option exercises.

The latest filing, published on 3 March 2022, reports a share grant in Greif, Inc. The clock since the last published purchase (8 September 2011) now reads 5,540 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to John F. Finn

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations43 total

25 of 43 declarations